|
|||||||||
|
|||||||||
|
|||||||||
 |
|||||||||
| |
||
|
|
|
|
|||||||||
|
|||||||||
|
|||||||||
|
|||||||||
| |
||
|
|
|
| |||||||||
 |
|
|
«
Previous Thread
|
Next Thread
»
|
Thread Tools | Search this Thread | Rate Thread | Display Modes |
SEO Chat Forums Sponsor:
|
|
|
|
#1
March 2nd, 2005, 02:00 PM
|
|||
|
|||
|
Chiron Flu Shot OK'd, But Rivals Loom (Reuters)
Reuters - Chiron Corp may get its flu
vaccine back on the U.S. market next winter thanks to a decision on Wednesday by British regulators, but rival products will limit demand and profitability of the vaccine in coming years, analysts said. View the Entire Article
|
|
| Viewing: SEO Chat Forums > Latest News Updated Hourly > Business News > Chiron Flu Shot OK'd, But Rivals Loom (Reuters) |
| Thread Tools | Search this Thread |
| Display Modes | Rate This Thread |
|
|
|
 |
|
|
|
|
|
Del.icio.us
Digg
Google
Spurl
Blink
Furl
Simpy
Y! MyWeb
Linear Mode
